lushington house, 119 high street, newmarket, suffolk, CB8 9AE
Website
-
al asayl bloodstock ltdEstimated Valuation
£355m
Pomanda estimates the enterprise value of AL ASAYL BLOODSTOCK LTD at £355m based on a Turnover of £2.1b and 0.17x industry multiple (adjusted for size and gross margin).
al asayl bloodstock ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of AL ASAYL BLOODSTOCK LTD at £0 based on an EBITDA of £-571.3k and a 0.72x industry multiple (adjusted for size and gross margin).
al asayl bloodstock ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of AL ASAYL BLOODSTOCK LTD at £0 based on Net Assets of £-17.7m and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Al Asayl Bloodstock LtdOverview
Al Asayl Bloodstock Ltd is a live company located in newmarket, CB8 9AE with a Companies House number of 08270109. It operates in the activities of racehorse owners sector, SIC Code 93191. Founded in October 2012, it's largest shareholder is
shaikha alyazia bint sultan bin khalifa al nahyan
with a 100% stake. Al Asayl Bloodstock Ltd is a established,
mega sized company, Pomanda has estimated its turnover at
£2.1b with
rapid
growth in recent years.
Pomanda's financial health check has awarded Al Asayl Bloodstock Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 1 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
7 Strong
2 Regular
1 Weak
Size
annual sales of £2.1b, make it larger than the average company (£647.5k)
£2.1b - Al Asayl Bloodstock Ltd
£647.5k - Industry AVG
Growth
3 year (CAGR) sales growth of 200%, show it is growing at a faster rate (4.8%)
200% - Al Asayl Bloodstock Ltd
4.8% - Industry AVG
Production
with a gross margin of -47.1%, this company has a higher cost of product (-5.2%)
-47.1% - Al Asayl Bloodstock Ltd
-5.2% - Industry AVG
Profitability
an operating margin of 0% make it more profitable than the average company (-46.3%)
0% - Al Asayl Bloodstock Ltd
-46.3% - Industry AVG
Employees
with 5165 employees, this is above the industry average (2)
5165 - Al Asayl Bloodstock Ltd
2 - Industry AVG
Pay Structure
on an average salary of £5.6k, the company has an equivalent pay structure (£5.6k)
£5.6k - Al Asayl Bloodstock Ltd
£5.6k - Industry AVG
Efficiency
resulting in sales per employee of £413.7k, this is more efficient (£146k)
£413.7k - Al Asayl Bloodstock Ltd
£146k - Industry AVG
Debtor Days
it gets paid by customers after 4 days, this is near the average (5 days)
4 days - Al Asayl Bloodstock Ltd
5 days - Industry AVG
Creditor Days
its suppliers are paid after 5 days, this is slower than average (4 days)
5 days - Al Asayl Bloodstock Ltd
4 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Al Asayl Bloodstock Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Al Asayl Bloodstock Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 169.6%, this is a lower level of debt than the average (424.1%)
169.6% - Al Asayl Bloodstock Ltd
424.1% - Industry AVG
AL ASAYL BLOODSTOCK LTD financials
EXPORT
Al Asayl Bloodstock Ltd's latest turnover from December 2023 is estimated at £2.1 billion and the company has net assets of -£17.7 million. According to their latest financial statements, we estimate that Al Asayl Bloodstock Ltd has 5,165 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Turnover
2,136,694,226
159,546,719
97,858,406
79,429,957
52,665,497
41,347,177
24,737,793
2,173,759
706,740
15,870,033
28,026,848
Other Income Or Grants
Cost Of Sales
3,142,908,343
421,979,402
258,822,193
187,906,598
143,606,472
129,305,570
41,006,633
1,188,972
516,672
36,198,864
25,430,425
Gross Profit
-1,006,214,117
-262,432,683
-160,963,787
-108,476,641
-90,940,975
-87,958,393
-16,268,841
984,787
190,068
-20,328,831
2,596,423
Admin Expenses
-1,005,642,793
-262,111,390
-160,425,601
-107,931,934
-90,071,076
-84,457,202
-13,304,795
-1,206,595
92,184
-17,041,696
4,701,049
Operating Profit
-571,324
-321,293
-538,186
-544,707
-869,899
-3,501,191
-2,964,046
2,191,382
97,884
-3,287,135
-2,104,626
Interest Payable
Interest Receivable
79
200
482
791
27
Pre-Tax Profit
-571,324
-321,293
-538,186
-544,707
-869,820
-3,500,991
-2,963,564
-1,206,595
-797,736
-3,286,344
-2,104,599
Tax
Profit After Tax
-571,324
-321,293
-538,186
-544,707
-869,820
-3,500,991
-2,963,564
-1,206,595
-797,736
-3,286,344
-2,104,599
Dividends Paid
Retained Profit
-571,324
-321,293
-538,186
-544,707
-869,820
-3,500,991
-2,963,564
-1,206,595
-797,736
-3,286,344
-2,104,599
Employee Costs
28,924,430
7,130,216
13,520
9,264
6,650
6,366
71,108
9,905
4,714
44,755
Number Of Employees
5,165
1,213
2
2
2
2
14
2
1
10
43
EBITDA*
-571,324
-321,293
-538,186
-544,707
-869,899
-3,501,191
-2,964,046
2,191,382
97,884
-3,287,135
-2,104,626
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Tangible Assets
18,000
18,000
18,000
18,000
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
18,000
18,000
18,000
18,000
Stock & work in progress
1,015,000
13,832,500
14,515,100
13,687,000
10,858,000
11,340,000
Trade Debtors
25,380,114
25,924,002
25,873,615
22,483,672
1,032,305
606,798
801,928
817,396
1,020,253
82,299
16,890
Group Debtors
Misc Debtors
Cash
21,084
32,286
160,437
82,230
305,742
10,612
misc current assets
total current assets
25,380,114
25,924,002
25,873,615
22,483,672
1,032,305
1,642,882
14,666,714
15,492,933
14,789,483
11,246,041
11,367,502
total assets
25,398,114
25,942,002
25,891,615
22,501,672
1,032,305
1,642,882
14,666,714
15,492,933
14,789,483
11,246,041
11,367,502
Bank overdraft
Bank loan
Trade Creditors
43,078,273
43,050,837
42,679,157
38,751,028
16,736,954
16,477,611
26,000,452
23,863,107
21,953,062
16,636,884
13,472,001
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
43,078,273
43,050,837
42,679,157
38,751,028
16,736,954
16,477,611
26,000,452
23,863,107
21,953,062
16,636,884
13,472,001
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
43,078,273
43,050,837
42,679,157
38,751,028
16,736,954
16,477,611
26,000,452
23,863,107
21,953,062
16,636,884
13,472,001
net assets
-17,680,159
-17,108,835
-16,787,542
-16,249,356
-15,704,649
-14,834,729
-11,333,738
-8,370,174
-7,163,579
-5,390,843
-2,104,499
total shareholders funds
-17,680,159
-17,108,835
-16,787,542
-16,249,356
-15,704,649
-14,834,729
-11,333,738
-8,370,174
-7,163,579
-5,390,843
-2,104,499
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Operating Activities
Operating Profit
-571,324
-321,293
-538,186
-544,707
-869,899
-3,501,191
-2,964,046
2,191,382
97,884
-3,287,135
-2,104,626
Depreciation
Amortisation
Tax
Stock
-1,015,000
-12,817,500
-682,600
828,100
2,829,000
-482,000
11,340,000
Debtors
-543,888
50,387
3,389,943
21,451,367
425,507
-195,130
-15,468
-202,857
937,954
65,409
16,890
Creditors
27,436
371,680
3,928,129
22,014,074
259,343
-9,522,841
2,137,345
1,910,045
5,316,178
3,164,883
13,472,001
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
18,000
-21,063
-11,402
-128,633
3,476,184
1,647,108
294,339
10,485
Investing Activities
capital expenditure
-18,000
Change in Investments
cash flow from investments
-18,000
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-100
-975,000
100
interest
79
200
482
791
27
cash flow from financing
-21
200
482
-975,000
791
127
cash and cash equivalents
cash
-21,084
-11,202
-128,151
78,207
-223,512
295,130
10,612
overdraft
change in cash
-21,084
-11,202
-128,151
78,207
-223,512
295,130
10,612
al asayl bloodstock ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for al asayl bloodstock ltd. Get real-time insights into al asayl bloodstock ltd's credit score, group structure and payment trends.
Perform a competitor analysis for al asayl bloodstock ltd by selecting its closest rivals, whether from the ARTS, ENTERTAINMENT AND RECREATION sector, other mega companies, companies in CB8 area or any other competitors across 12 key performance metrics.
al asayl bloodstock ltd Ownership
AL ASAYL BLOODSTOCK LTD group structure
Al Asayl Bloodstock Ltd has no subsidiary companies.
Ultimate parent company
AL ASAYL BLOODSTOCK LTD
08270109
AL ASAYL BLOODSTOCK LTD Shareholders
The sole shareholder of Al Asayl Bloodstock Ltd is Shaikha Alyazia Bint Sultan Bin Khalifa Al Nahyan.
shaikha alyazia bint sultan bin khalifa al nahyan
100%
al asayl bloodstock ltd directors
Al Asayl Bloodstock Ltd currently has 3 directors.
The longest serving directors include
Mrs Isabel Peter-Hoblyn (Oct 2012) and
Mr John Peter-Hoblyn (Oct 2016).
lushington house, 119 high street, newmarket, suffolk, CB8 9AE
Bank
-
Legal Advisor
-
al asayl bloodstock ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to al asayl bloodstock ltd.
al asayl bloodstock ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AL ASAYL BLOODSTOCK LTD. This can take several minutes, an email will notify you when this has completed.
al asayl bloodstock ltdCompanies House Filings - See Documents
